Table 2.

Univariate analysis of HT after intravenous thrombolysis in AIS patients (n, %).

Factors		No HT group (n = 200)	HT group (n = 48)	χ 2 value	P value
Gender	Male	145	35	1.003	0.954
	Female	55	13
Age (years)	≤65	97	33	6.364	0.012
	>65	103	15
Weight (kg)	≤70	88	23	0.240	0.624
	>70	122	25
History of hypertension	Yes	113	23	1.152	0.283
	No	87	25
History of diabetes	Yes	98	20	0.835	0.361
	No	102	28
History of cerebral infarction	Yes	91	27	1.794	0.080
	No	109	21
History of coronary heart disease	Yes	79	26	3.411	0.065
	No	121	22
Atrial fibrillation	Yes	84	30	6.550	0.010
	No	116	18
Smoking history	Yes	85	27	2.956	0.086
	No	115	21
Drinking history	Yes	121	25	1.133	0.287
	No	79	23
Baseline NIHSS score (point)	≤14	102	15	6.059	0.014
	>14	98	33
Baseline systolic pressure (mmHg)	≤155	90	15	2.998	0.083
	>155	110	33
Baseline blood glucose (mmol/L)	≤7.8	119	18	7.578	0.006
	>7.8	81	30
Early signs of infarction on admission with head CT	Yes	99	32	4.578	0.032
	No	101	16
Time from onset to thrombolytic therapy (h)	≤3	90	8	13.002	≤0.01
	>3, and ≤4.5	110	40
Thrombolytic drugs	rt-PA	98	12	9.034	0.003
	Urokinase	102	36